DRUG DISCOVERY AND DEVELOPMENT OPTION AND LICENSE AGREEMENTDrug Discovery and Development Option and License Agreement • November 1st, 2013 • Array Biopharma Inc • Pharmaceutical preparations • New York
THIS DRUG DISCOVERY AND DEVELOPMENT OPTION AND LICENSE AGREEMENT (the “Agreement”) is made effective as of July 17, 2013 (“Effective Date”) by and between Array BioPharma Inc., a Delaware corporation, having its principal offices located at 3200 Walnut, Boulder, CO 80301 (“Array”), and Celgene Corporation, a Delaware corporation, having its principal offices located at 86 Morris Avenue, Summit, NJ 07901 (“Celgene U.S.”) and Celgene Alpine Investment Co., LLC, a Delaware limited liability company located at 86 Morris Avenue, Summit, New Jersey 07901, United States of America (“Alpine” and, collectively, with Celgene U.S., “Celgene”).
